ロード中...
Targeting Specific Cells in the Brain with Nanomedicines for CNS Therapies
Treatment of Central Nervous System (CNS) disorders still remains a major clinical challenge. The Blood-brain-barrier (BBB), known as the major hindrance, greatly limits therapeutics penetration into the brain. Moreover, even though some therapeutics can cross BBB based on their intrinsic properties...
保存先:
| 出版年: | J Control Release |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4903089/ https://ncbi.nlm.nih.gov/pubmed/26686078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2015.12.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|